Reza Alipanah-Moghadam

Dr. Reza Alipanah-Moghadam


Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 December 2019 in Drug Design, Development and Therapy
Verified
Journal Article
Open access
PDF file
ANAli Nemati
Ali Nemati
RAReza Alipanah-Moghadam
Reza Alipanah-Moghadam
LMLeila Molazadeh
Leila Molazadeh
ABAbbas Naghizadeh Baghi
Abbas Naghizadeh Baghi
Background: Glutamine is the most abundant amino acid in plasma and skeletal muscles and an important fuel for immune system cells. It has beneficial anti-inflammatory and antioxidant properties which may be considered as a potentially useful supplement for athletes. The present study was conducted to investigate the effect of glutamine supplementation on oxidative stress and matrix metalloproteinase 2 and 9 after exhaustive exercise in young healthy males. Materials and methods: In this study, 30 healthy males (supplement =15 and control=15) were randomly assigned into two groups. The supplement group received 0.3 g/kg BW of glutamine along with 25 gr of sugar dissolved in 250 cc water per day. The control group received 25 gr of sugar in 250 cc water per day. Fasting blood samples were taken at baseline and at the end of 14 days of intervention. The participants underwent exercise until experiencing full-body exhaustive fatigue for 16 ± 2.84 mins, and then fasting blood samples were taken. Serum levels of TAC, MDA, MMP2, MMP9, glutathione, and hs-CRP were measured. Results: Serum levels of MDA and hs-CRP significantly decreased in the supplement group (p< 0.05). The serum level of TAC significantly increased in the supplement group (p< 0.05). Glutathione serum levels significantly increased after exhaustive exercise (p< 0.05). Serum levels of MMP2 and MMP9 remained unchanged. Conclusion: Results of this study showed that, some biochemical factors are time-dependent and can increase or decrease over time, as well as, serum levels of hs-CRP and MDA decreased with glutamine supplementation along with the increase in the TAC serum levels, but this supplementation had no effect on serum levels of MMP2 and MMP9 in exhaustive exercise.

12 September 2023 in Scientific Reports
Verified
Journal Article
Open access
PDF file
HRHamed Rezaie
Hamed Rezaie
RAReza Alipanah-Moghadam
Reza Alipanah-Moghadam
FJFarhad Jeddi
Farhad Jeddi
CCCain C. T. Clark
Cain C. T. Clark
VAvahideh aghamohammadi
vahideh aghamohammadi
ANAli Nemati
Ali Nemati
Breast cancer is one of the most prevalent and deadly cancers among women worldwide. Recently, natural compounds have been widely used for the treatment of breast cancer. Present study evaluated antiproliferative and anti-metastasis activities of two natural compounds of dandelion and all-trans-retinoic acid (ATRA) in human MCF-7 and MDA-MB231 breast cancer cells. We also evaluated the expression of MMP-2, MMP-9, IL-1β, p53, NM23 and KAI1 genes. Data showed a clear additive cytotoxic effect in concentrations of 40 μM ATRA with 1.5 and 4 mg/ml of dandelion extract in MCF-7 and MDA-MB231 cells, respectively. In both cell lines, compared with the untreated cells, the expression levels of MMP-9 and IL-1β were significantly decreased while p53 and KAI1 expression levels were increased. Besides, MMP-2 and NM23 had different expressions in the two studied cell lines. In conclusion, dandelion/ATRA co-treatment, in addition to having strong cytotoxic effects, has putative effects on the expression of anti-metastatic genes in both breast cancer cells.

1 October 2019 in Asian Pacific Journal of Cancer Prevention
Verified
Journal Article
Open access
PDF file
SHSara Hosseinzadeh
Sara Hosseinzadeh
RAReza Alipanah-Moghadam
Reza Alipanah-Moghadam
FAFazel Isapanah Amlashi
Fazel Isapanah Amlashi
ANAli Nemati
Ali Nemati
Introduction: Esophageal cancer is one of the most lethal gastrointestinal cancers that has a complex and diverse etiology, with several genetic and nutritional factors involved in its etiology. The purpose of this study was to investigate the type of haptoglobin genotype and its relationship with some nutritional and biochemical risk factors affecting the prevalence of esophageal cancer in patients with early stage esophageal cancer. Materials and methods: In this study, 44 patients (20 males and 24 females) with early stage esophageal cancer and 44 healthy subjects, classified as control group, (19 males and 25 females) were selected. Haptoglobin (HP) genotype was determined employing PCR technique. Nutritional data were analyzed using standard food frequency questionnaire (FFQ) method. Serum levels of malondialdehyde (MDA), nitrate and nitrite were measured employing the colorimetric method. Serum levels of p53 protein were measured using the enzyme-linked immunosorbent assay (ELISA) technique. Results: The results of our study showed for the first time that HP1-1 genotype was the most prevalent genotype in esophageal cancer patients in Golestan province, Iran. HP2-2 genotype was the most frequent in the control group. Serum levels of MDA were significantly higher in the patients’ group compared to the control group (P˂0.001). Weight and body mass index (BMI) were significantly lower in the patients’ group than the control group (P<0.01). Food frequency analysis revealed that the consumption of fruits and vegetables in the patients’ group was lower than that of the control group (P<0.05). Conclusion: The results of our study showed for the first time that HP1-1 genotype is the dominant genotype in patients with esophageal cancer in Golestan province. As well, modification of nutritional pattern and consumption of high level of antioxidant compounds can be effective in reducing the prevalence of esophageal cancer in this region.

1 March 2016
Verified
Journal Article
Closed access
ABAbbas Naghizadeh Baghi
Abbas Naghizadeh Baghi
MMMohammad Mazani
Mohammad Mazani
ANAli Nemati
Ali Nemati
MAMojtaba Amani
Mojtaba Amani
SASeyedyashar Alamolhoda
Seyedyashar Alamolhoda
RAReza Alipanah-Moghadam
Reza Alipanah-Moghadam

1 March 2019
Verified
Journal Article
Closed access
ANAli Nemati
Ali Nemati
RAReza Alipanah-Moghadam
Reza Alipanah-Moghadam
MMMohammad Mazani
Mohammad Mazani
ADAkram Darvishi
Akram Darvishi

1 July 2018
Verified
Journal Article
Open access
PDF file
NKNasim Rahmani Kukia
Nasim Rahmani Kukia
RAReza Alipanah-Moghadam
Reza Alipanah-Moghadam
NDNowruz Delirezh
Nowruz Delirezh
MMMohammad Mazani
Mohammad Mazani
Background: Immunotherapy is one promising therapeutic strategy against glioma, an aggressive form of braincancer. Previous studies have demonstrated that multiple tumor antigens exist and can be used to induce tumor specificT cell responses. Furthermore, recently it was shown that TLR4-primed mesenchymal stem cells (MSCs), also knownas MSC1, mostly elaborate pro-inflammatory mediators. Compared to MSCs, MSC-derived microvesicles (MVs) haveadvantageous properties that present them as stable, long lasting effectors with no risk of immune rejection. Therefore,peripheral blood monocyte derived dendritic cells (MoDCs) have been used to load tumor antigens and stimulate Tcell mediated responses in the presence of MSC1-derived MVs in vitro. Methods: The B92 tumor cell line was heatedto 43°C for 90 min prior to preparation of tumor cell lysates. MVs were purified by differential ultracentrifugationafter isolation, stimulation of proliferation and treatment of MSCs. Autologous T cells isolated from non-adherentcells were harvested during the procedure to generate MoDCs and then incubated with heat stressed tumor cell lysatepulsed DCs in the presence of MSC1-derived MVs. T cells were then co-cultured with tumor cells in 96-well plates ata final volume of 200 μl CM at an effector: target ratio of 100:1 to determine their specific cytotoxic activity. Results:Flow cytometric analysis, T cell mediated cytotoxicity showed that heat stressed tumor antigen pulsed MoDCs andMSC1-derived MVs primed T cells elicited non-significantly enhanced cytotoxic activity toward B92 tumor cells(P≥0.05). Conclusion: These findings may offer new insights into tumor antigen presenting technology involvingdendritic cells and MSC1-derived MVs. Further exploration of the potential of such nanoscale particles in immunotherapyand in novel cancer vaccine settings appears warranted.